We have been selected by Swissnex to join the India Market Entry camp. Our team will travel to India to strengthen its market entry strategy for this important market.
We are also negotiating OEM agreements with our suppliers, enabling us to sell a Clemedi branded box with all reagents. You can see our current renders for what this box might look like below.
Implemented several new features in our software to help physicians interpret our results within known reference points. For this we added a WHO curated list of resistance confering mutations as well as generated known line-probe assay blots in the user interface as seen below.
We kicked off documentation of all product specifications and parameters under an ISO13485 quality management system with the help of Effectum Medical.
We are closing a last addition to our first financing round to further help us reach our goals. Details will follow.